Quinndora M. Byrd

Quinndora M. Byrd serves as a Contract Specialist within the FA5000 673 Cons Lgc under the Department of the Air Force, where she plays a pivotal role in executing procurement strategies that sustain critical military infrastructure and operational readiness. She manages the full lifecycle of complex acquisitions spanning construction, environmental remediation, medical equipment, and facility services, ensuring compliance with FAR regulations and mission-aligned delivery. Her work directly supports the Air Force’s mission to maintain high-readiness installations through timely, compliant, and cost-effective contracting solutions for both institutional and specialized technical requirements. Byrd maintains consistent working relationships with key contractors including GIGABITER LLC, VINDICATOR TECHNOLOGIES, INC., YUKON EQUIPMENT, INC., and GLOBAL FINISHING SOLUTIONS LLC, partnering with firms that deliver specialized construction, electrotherapeutic systems, and facility maintenance services. Her procurement approach emphasizes vendor reliability, technical capability, and performance history, fostering long-term partnerships with contractors experienced in defense-related environments and regulatory compliance. Her contracting patterns reflect a strong commitment to small business participation, with 36% of her awards structured as Total Small Business Set-Asides under FAR 19.5. While the majority of acquisitions remain open to full and open competition, she actively prioritizes opportunities for small businesses, aligning with Department of Defense socioeconomic goals without compromising mission requirements. Byrd’s primary NAICS focus includes Construction Machinery Manufacturing (333120), Commercial and Institutional Building Construction (236220), and Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), demonstrating deep expertise in procuring heavy equipment, facility upgrades, and medical devices for military health and operational support. Her domain knowledge extends to remediation services and medical laboratory infrastructure, ensuring technical precision and regulatory alignment across high-stakes acquisitions.